3TOP
Crystral Structure of the C-terminal Subunit of Human Maltase-Glucoamylase in Complex with Acarbose
Summary for 3TOP
Entry DOI | 10.2210/pdb3top/pdb |
Related | 3TON |
Related PRD ID | PRD_900007 |
Descriptor | Maltase-glucoamylase, intestinal, 4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose (3 entities in total) |
Functional Keywords | membrane, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Apical cell membrane; Single-pass type II membrane protein: O43451 |
Total number of polymer chains | 2 |
Total formula weight | 208745.59 |
Authors | |
Primary citation | Ren, L.M.,Qin, X.H.,Cao, X.F.,Wang, L.L.,Bai, F.,Bai, G.,Shen, Y. Structural insight into substrate specificity of human intestinal maltase-glucoamylase Protein Cell, 2:827-836, 2011 Cited by PubMed Abstract: Human maltase-glucoamylase (MGAM) hydrolyzes linear alpha-1,4-linked oligosaccharide substrates, playing a crucial role in the production of glucose in the human lumen and acting as an efficient drug target for type 2 diabetes and obesity. The amino- and carboxyl-terminal portions of MGAM (MGAM-N and MGAM-C) carry out the same catalytic reaction but have different substrate specificities. In this study, we report crystal structures of MGAM-C alone at a resolution of 3.1 Å, and in complex with its inhibitor acarbose at a resolution of 2.9 Å. Structural studies, combined with biochemical analysis, revealed that a segment of 21 amino acids in the active site of MGAM-C forms additional sugar subsites (+ 2 and + 3 subsites), accounting for the preference for longer substrates of MAGM-C compared with that of MGAM-N. Moreover, we discovered that a single mutation of Trp1251 to tyrosine in MGAM-C imparts a novel catalytic ability to digest branched alpha-1,6-linked oligosaccharides. These results provide important information for understanding the substrate specificity of alpha-glucosidases during the process of terminal starch digestion, and for designing more efficient drugs to control type 2 diabetes or obesity. PubMed: 22058037DOI: 10.1007/s13238-011-1105-3 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.881 Å) |
Structure validation
Download full validation report